What is she best known for?
The fields of study she is best known for:
- Cancer
- Immune system
- Gene
Laurence Zitvogel mainly investigates Immune system, Immunology, Cell biology, Cancer research and Programmed cell death.
Much of her study explores Immune system relationship to Cancer cell.
Her study ties her expertise on Cancer together with the subject of Immunology.
Her biological study spans a wide range of topics, including Autophagy, Dendritic cell, Follicular dendritic cells and Heat shock protein.
Laurence Zitvogel focuses mostly in the field of Cancer research, narrowing it down to matters related to Tumor necrosis factor alpha and, in some cases, CD49b.
Laurence Zitvogel combines subjects such as Calreticulin, Endoplasmic reticulum and Cell culture with her study of Programmed cell death.
Her most cited work include:
- Exosomes: composition, biogenesis and function (3388 citations)
- Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. (2180 citations)
- Calreticulin exposure dictates the immunogenicity of cancer cell death (1963 citations)
What are the main themes of her work throughout her whole career to date?
Her scientific interests lie mostly in Immune system, Immunology, Cancer research, Cancer and Immunotherapy.
Her Immune system research includes themes of Cancer cell, Cytotoxic T cell, Antigen and Cell biology.
Her Cancer research research is multidisciplinary, relying on both Cell, Chemotherapy, Apoptosis, CD8 and Receptor.
Her Cancer study combines topics in areas such as Gut flora, Clinical trial, Bioinformatics and Radiation therapy.
Her study in Immunotherapy is interdisciplinary in nature, drawing from both Melanoma and Oncology.
In her research, Immunogenicity is intimately related to Calreticulin, which falls under the overarching field of Immunogenic cell death.
She most often published in these fields:
- Immune system (62.08%)
- Immunology (55.94%)
- Cancer research (43.52%)
What were the highlights of her more recent work (between 2017-2021)?
- Cancer research (43.52%)
- Immune system (62.08%)
- Cancer (30.97%)
In recent papers she was focusing on the following fields of study:
Her primary areas of investigation include Cancer research, Immune system, Cancer, Immunotherapy and Immunogenic cell death.
The various areas that Laurence Zitvogel examines in her Cancer research study include Cancer cell, Cytotoxic T cell, Calreticulin and CD8.
Her Immune system study is focused on Immunology in general.
The study incorporates disciplines such as Myelopoiesis and Calprotectin in addition to Immunology.
Her Cancer research is multidisciplinary, incorporating perspectives in Disease, Dysbiosis and Chemotherapy.
Her Immunogenic cell death research is multidisciplinary, incorporating elements of Autophagy, Mitoxantrone and Neuroscience.
Between 2017 and 2021, her most popular works were:
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors (1889 citations)
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. (1747 citations)
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients (1619 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Gene
- Immune system
Her primary areas of study are Cancer research, Immune system, Immunotherapy, Cancer and Immunology.
The concepts of her Cancer research study are interwoven with issues in Cancer cell, Immunogenic cell death and Interferon.
The Immune system study combines topics in areas such as Chemotherapy and Antigen.
Laurence Zitvogel interconnects Microbiome, Blockade, Antibiotics and Akkermansia muciniphila in the investigation of issues within Immunotherapy.
Her Cancer research integrates issues from Toll-like receptor, Disease and Oncology.
The various areas that Laurence Zitvogel examines in her Immunology study include Myelopoiesis and Calprotectin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
